First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours
- Conditions
- Bladder Cancer
- Interventions
- Procedure: En-Bloc Resection of Bladder Tumours
- Registration Number
- NCT06281080
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 10
- Age between 18 and 75 years
- Body mass index <35 kg/m2
- Bladder tumour located <3 cm in size; clinically non-muscle invasive bladder tumour
- Clinically indicated for en-bloc resection.
- Willingness to participate as demonstrated by giving informed consent
- Presence of endoscopic or imaging signs of detrusor muscle invasion
- Contraindication to general anaesthesia / spinal anaesthesia
- ASA > 2 patients
- Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
- Untreated active infection
- Un-corrected coagulopathy
- Presence of another malignancy or distant metastasis
- Emergency surgery
- Vulnerable population (e.g. mentally disabled, pregnant)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Treatment arm En-Bloc Resection of Bladder Tumours Patients underwent En-Bloc Resection of Bladder Tumours using Agilis Robotic System.
- Primary Outcome Measures
Name Time Method Successful en-bloc tumour resection by the robotic system During the operation The number of cases completed the intervention by robotic system
- Secondary Outcome Measures
Name Time Method Dissection time and speed During operation Time required for submucosal dissection from the first cut
Presence of detrusor muscle in specimen During operation Presence of detrusor muscle in specimen
Post-operative complications Within 30 days after the study intervention Complication is defined according to the Clavien-Dindo Classification
Surgeon Console time During operation From the time start of any procedure to completion of urethral catheter insertion
Total procedure time During operation Time from insertion of the robotic system into urethra until removal of the specimen from the body
Resection Margin During operation Number of subject with Negative resection margin
Intra-operative bladder perforation event During operation Number of subject
Need of bladder irrigation Within 30 days after the study intervention. Number of subject
Residual tumour or upstaging of tumour after second look TURBT Within 30 days after the study intervention. Number of subject